Search

everythinglearnresearchcommunity

for

Search:↓

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Dupilumab can cause lupus-like symptoms, so patients need careful monitoring.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Denosumab may cause alopecia areata.

An arthritis drug helped a person with severe hair loss regrow their hair.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Baricitinib may help people with long-term alopecia areata.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.